AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Intelliseq at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Intelliseq brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 1904. Its sessions cover making pharmacogenomics results usable in the clinic and interpreting somatic cancer variants with the Cancer Knowledgebase and its GeneSpect Somatic Reporter. Both run from variant interpretation to reporting, using automated analysis.

OrganizationAMP 2026 Attendance
Intelliseq
Krakow, Poland
Software
iFlow cloud platform automating genomic data analysis and reporting for pharmacogenomics, germline disorders, somatic cancer and polygenic risk scores.
Booth
Exhibiting at Booth 1904
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Fri, Nov 13
12:40pm–1:10pm
Making Pharmacogenomics Actionable: From Variant Interpretation to Clinical Decisions
Software that turns pharmacogenetic panel results into interpreted reports and prescribing guidance, extending existing commercial panels.
Workshop
Sat, Nov 14
12:00pm–12:30pm
From Complexity to Clarity: Reimagining Somatic Variant Interpretation with Cancer Knowledgebase (CKB) and GeneSpect Somatic Reporter
Pairing a literature-curated cancer knowledgebase with reporting software to speed and standardise somatic variant interpretation in labs.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Intelliseq

Tell us what you sell and we’ll find the people at Intelliseq most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction